Acceptance and Commitment Therapy for Adolescents and Young Adults With Sickle Cell Disease

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age14-21
SponsorChildren's Hospital Los Angeles

About this trial

The current study seeks to build on previous research that demonstrates the efficacy of Acceptance and Commitment Therapy in combating stigma by investigating the feasibility and acceptability of a protocol to support Black adolescents and young adults in coping with race related stress. The study will consist of a small, purposeful, non-randomized sample (N = 30) of clients enrolled into a 10-session Acceptance and Commitment Therapy group. The group will be offered as part of regular clinical care at the Division of Adolescent and Young Adult Medicine. Three consecutive groups will be run with approximately 8-10 participants in each group over the next year.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • ACT for SCD

Treatment groups

66 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Children's Hospital Los Angeles

Lead sponsor

University of Southern California & Children's Hospital Los Angeles (USC-CHLA)

Collaborator